and no = 205

KOVIcheck COVID-19 IgG/IgM (ProteomeTech Inc)

KOVIcheck COVID-19 IgG/IgM

  • HS Code
  • Certification CE-IVD, EUA notification
  • Patent
  • Awards
  • Features
    KOVIcheck COVID-19 IgG/IgM is an Immunochromatographic assay for the detection of SARS-CoV-2 specific human Immunoglobulin G and Immunoglobulin M in serum/ plasma/ venous whole blood (finger prick or venous). KOVIcheck COVID-19 IgG/IgM detects the virus-specific antibodies, which are made in response to the infection of SARS-CoV-2. The person who had an immune response to COVID-19 has specific antibodies that can be diagnosed with the disease regardless of the symptom.Immunochromatographic assay for detection of SARS-CoV-2 specific human Immunoglobulin G and Immunoglobulin M.

    View more

Product details



 

Company Information

ProteomeTech Inc

Company Profile Download

Address : A-702 Gangseo hangang Xi Tower, 401 Yangcheon-ro, Gangseo-gu, Seoul 07528 Korea

Website : http://http://www.proteometech.com/

Proteometech Inc. aims to contribute to human health and well-being through finding new protein targets for disease prediction, early diagnosis, and development of new medicines. Based on our dedication for identification of bio-markers needed in early diagnosis of incurable diseases with and our advanced technology in "protein analysis" we have successfully developed unique in vitro diagnosis merchandise such as allergy diagnosis kits, immunity monitoring kits and next-generation pregnancy diagnosis kits, and are currently developing early cancer diagnosis kits. As a manufacturer of award-winning in vitro diagnostic medical devices (Jang Yeongsil Award, New Excellent Technology (NET), World-Class Products and more), Proteometech is a group of talented individuals striving for production of the World's Best Products with strong passion and skills.